IBDRY vs ISRG
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
IBDRY · IBERDROLA SA SPON ADR EACH REP 4 ORD$100.87 ▼ 1.02%
ISRG · Intuitive Surgical$452.80 ▼ 3.36%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- IBDRY +23.5%
- ISRG -21.4%
Head to head
| Metric | IBDRY | ISRG |
|---|---|---|
| Price | $100.87 | $452.80 |
| Change today | ▼ 1.02% | ▼ 3.36% |
| Market cap | $156.40B | $156.96B |
| Return, 3 months | +6.4% | +15.1% |
| Return, year to date | +16.8% | -20.1% |
| Return, 1 year | +23.4% | -19.1% |
| P/E (TTM) | 29.2 | 54.8 |
| P/B | 2.9 | 9.8 |
| P/E percentile vs own 5y | – | 15th |
| Dividend yield | 3.11% | – |
| Revenue growth (YoY, latest qtr) | – | +21.7% |
| Net profit growth (YoY) | – | -26.1% |
| Gross margin | – | 67.2% |
| Operating margin | – | 32.3% |
| Net margin | – | 25.5% |
| Return on equity | – | 18.0% |
| Analyst target vs. price | – | +12.7% |
| Analyst buy share | – | 100% |
| RSI (14) | 66 | 57 |
| 30-day volatility | 15.9% | 40.1% |
| Max drawdown, 1 year | -9.2% | -44.0% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ISRG is the largest of the group by market value.
- IBDRY has returned the most over the past year.
- IBDRY carries the lowest trailing P/E.
- IBDRY has been the calmest stock over the last 30 days.